Atomic Interactions and Profile of Small Molecules Disrupting Protein-Protein Interfaces: the TIMBAL Database

被引:140
作者
Higueruelo, Alicia P. [1 ]
Schreyer, Adrian [1 ]
Bickerton, G. Richard J. [1 ]
Pitt, Will R. [1 ,2 ]
Groom, Colin R. [3 ]
Blundell, Tom L. [1 ]
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England
[2] UCB Celltech, Slough, Berks, England
[3] Cambridge Crystallog Data Ctr, Cambridge, England
基金
英国生物技术与生命科学研究理事会;
关键词
CREDO; database; druggable; drugs; multi-protein complexes; PICCOLO; protein-protein interactions; small molecules; TIMBAL; STRUCTURE-BASED DESIGN; HUMAN-PAPILLOMAVIRUS TYPE-11; E2 TRANSACTIVATION DOMAIN; ZIPA-FTSZ INTERACTION; LIGAND INTERACTION; POTENT INHIBITORS; DRUG CANDIDATES; BCL-2; PROTEINS; LEAD DISCOVERY; BINDING-SITE;
D O I
10.1111/j.1747-0285.2009.00889.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growing evidence of the possibility of modulating protein-protein interactions with small molecules is opening the door to new approaches and concepts in drug discovery. In this paper, we describe the creation of TIMBAL, a hand-curated database holding an up to date collection of small molecules inhibiting multi-protein complexes. This database has been analysed and profiled in terms of molecular properties. Protein-protein modulators tend to be large lipophilic molecules with few hydrogen bond features. An analysis of TIMBAL's intersection with other structural databases, including CREDO (protein-small molecule from the PDB) and PICCOLO (protein-protein from the PDB) reveals that TIMBAL molecules tend to form mainly hydrophobic interactions with only a few hydrogen bonding contacts. With respect to potency, TIMBAL molecules are slightly less efficient than an average medicinal chemistry hit or lead. The database provides a resource that will allow further insights into the types of molecules favoured by protein interfaces and provide a background to continuing work in this area. Access at http://www-cryst.bioc.cam.ac.uk/timbal.
引用
收藏
页码:457 / 467
页数:11
相关论文
共 61 条
  • [1] Adair J.R., 2005, DRUG DESIGN REV ONLI, V2, P209
  • [2] A gene-expression inhibitor that targets an α-helix-mediated protein interaction
    Asada, S
    Choi, YM
    Uesugi, M
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (17) : 4992 - 4993
  • [3] Modulation of protein-protein interactions with small organic molecules
    Berg, T
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (22) : 2462 - 2481
  • [4] Berg T, 2008, CURR OPIN DRUG DISC, V11, P666
  • [5] Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery
    Blundell, TL
    Sibanda, BL
    Montalvao, RW
    Brewerton, S
    Chelliah, V
    Worth, CL
    Harmer, NJ
    Davies, O
    Burke, D
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2006, 361 (1467) : 413 - 423
  • [6] Bioactivation and hepatotoxicity of nitroaromatic drugs
    Boelsterli, Urs A.
    Ho, Han Kiat
    Zhou, Shufeng
    Leow, Koon Yeow
    [J]. CURRENT DRUG METABOLISM, 2006, 7 (07) : 715 - 727
  • [7] Studies leading to potent, dual inhibitors of bcl-2 and Bcl-xL
    Bruncko, Milan
    Oost, Thorsten K.
    Belli, Barbara A.
    Ding, Hong
    Joseph, Mary K.
    Kunzer, Aaron
    Martineau, Darlene
    McClellan, William J.
    Mitten, Michael
    ng, Shi-Chu Ng
    Nimmer, Paul M.
    Oltersdorf, Tilman
    Park, Cheol-Min
    Petros, Andrew M.
    Shoemaker, Alexander R.
    Song, Xiaohong
    Wang, Xilu
    Wendt, Michael D.
    Zhang, Haichao
    Fesik, Stephen W.
    Rosenberg, Saul H.
    Elmore, Steven W.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) : 641 - 662
  • [8] Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein
    Chen, Jianyong
    Nikolovska-Coleska, Zaneta
    Wang, Guoping
    Qiu, Su
    Wang, Shaomeng
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (22) : 5805 - 5808
  • [9] A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export
    Daelemans, D
    Afonina, E
    Nilsson, J
    Werner, G
    Kjems, J
    De Clercq, E
    Pavlakis, GN
    Vandamme, AM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) : 14440 - 14445
  • [10] Characterization of the binding site for inhibitors of the HPV11 E1-E2 protein interaction on the E2 Transactivation domain by photoaffinity labeling and mass spectrometry
    Davidson, W
    McGibbon, GA
    White, PW
    Yoakim, C
    Hopkins, JL
    Guse, I
    Hambly, DM
    Frego, L
    Ogilvie, WW
    Lavallée, P
    Archambault, J
    [J]. ANALYTICAL CHEMISTRY, 2004, 76 (07) : 2095 - 2102